In particular, previous studies have shown that NRG1 promotes glucose uptake and mitochondrial oxidative metabolism to reduce blood sugar and weight gain, and more recent studies reported that NRG1 regulates the pathogenesis of NAFLD through ErbB3 signaling in hepatocytes. This evidence concerns the gene NRG1 and metabolic dysfunction-associated steatotic liver disease.